Management of Hypercholesterolemia and Hypertriglyceridemia
Assessment of Current Lipid Profile and Risk
- The patient has moderate hypertriglyceridemia with triglycerides of 322 mg/dL, which increases cardiovascular disease risk 1
- Total cholesterol of 211 mg/dL is above optimal levels, and the elevated non-HDL cholesterol further increases cardiovascular risk 2, 3
- Current psychiatric medications may be contributing to lipid abnormalities, as antipsychotics and certain psychiatric medications are known secondary causes of hypertriglyceridemia 1
Management Strategy
Step 1: Address Secondary Causes and Lifestyle Modifications
- Evaluate the contribution of psychiatric medications to lipid abnormalities - antipsychotics like ziprasidone and tricyclic antidepressants like amitriptyline can elevate triglycerides and cholesterol 1
- Implement intensive lifestyle interventions, including dietary counseling, weight loss, regular physical activity, and limitation of alcohol consumption 1, 4
Step 2: Pharmacological Management
- Initiate statin therapy as first-line treatment for both elevated cholesterol and moderate hypertriglyceridemia 2, 5
- For this patient with moderate hypertriglyceridemia, the treatment goal should be a non-HDL cholesterol level 30 mg/dL higher than the LDL goal 1